title: Management of male breast cancer.
abstract: Male breast cancer afflicts about 900 men a year in the U.S., of whom 300 die of their disease. General recommendations for treatment are similar to those for females: All patients with positive nodes and selected node-negative patients considered at high risk for recurrence are advised to have systemic therapy. Tamoxifen is often recommended because the majority of male breast cancers are estrogen and progesterone-receptor positive. No significant experience has been reported with primary radiation therapy to date.
authors.affiliation: Memorial Sloan-Kettering Cancer Center.
authors.forename: D W
authors.initials: DW
authors.lastname: Kinne
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male